Hirtle Callaghan & Co Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$587K |
| 2 |
Chevron
CVX
|
+$470K |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$383K |
| 4 |
Illinois Tool Works
ITW
|
+$371K |
| 5 |
Waste Management
WM
|
+$360K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$73.6M |
| 2 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
+$11.1M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.16M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$353K |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$200K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.23% |
| 2 | Healthcare | 1.99% |
| 3 | Financials | 1.39% |
| 4 | Industrials | 1.13% |
| 5 | Consumer Staples | 1.02% |
Similar funds
Hirtle Callaghan & Co's Q3 2016 Portfolio in Review
As of Q3 2016, Hirtle Callaghan & Co held 196 positions worth $484M, down 10% from $539M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Hirtle Callaghan & Co withdrew a net $79.8M in Q3 2016, closing 2 positions and reducing 11 holdings. Its most notable exit was iShares Currency Hedged MSCI EAFE ETF, an estimated $11.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.2% of assets, up from 2.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Hirtle Callaghan & Co opened a new position in Illinois Tool Works worth $386K.
- Hirtle Callaghan & Co's largest Q3 2016 buy was Illinois Tool Works: 3,200 shares worth $386K.
- Hirtle Callaghan & Co added most to Pfizer in Q3 2016, an estimated $587K increase.
- Hirtle Callaghan & Co's biggest Q3 2016 reduction was iShares MSCI EAFE ETF, cutting an estimated $73.6M.
- Hirtle Callaghan & Co fully exited iShares Currency Hedged MSCI EAFE ETF in Q3 2016, selling an estimated $11.1M.
- Hirtle Callaghan & Co's ten largest holdings make up 83% of its $484M portfolio in Q3 2016.
- Hirtle Callaghan & Co opened 28 new positions and closed 2 in Q3 2016.
- Hirtle Callaghan & Co's portfolio value fell 10% quarter-over-quarter to $484M.
Based on Hirtle Callaghan & Co's 13F filing for Q3 2016, filed 7 Nov 2016.